Fernandez, Jenalyn .
HRN: 26-79-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/22/2025
03/28/2025
IV
45
Q24
NEONATAL PNEUMONIA
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes